Offshore
Photo
โ InsideArbitrage
๐Ÿš€ $CRM Salesforce announced Robin Washington will become President & Chief Operating and Financial Officer (COFO) on March 21, 2025.

๐Ÿ’ผ Washington has held key roles at Gilead Sciences, Hyperion, and PeopleSoft. She has served on Salesforceโ€™s board since 2013 and is currently a director at Alphabet, Honeywell, and other companies.

๐Ÿ”„ COO Brian Millham to retire on May 1, 2025, after 25 years at Salesforce. He will transition into an advisory role.

- Amy Weaver, the current CFO, announced last year that she would be transitioning from Salesforce once a new CFO was named.

๐Ÿ“ˆ Salesforce stock is up 86% in the last 5 years!
tweet
Offshore
Photo
โ InsideArbitrage
TPG $TPG to Acquire Altus Power $AMPS in a $2.2 Billion All-Cash Deal -
โ˜€๏ธAltus Power will be acquired by TPG through its TPG Rise Climate Transition Infrastructure strategy for $5 per share of its Class A common stock in an all-cash transaction. The deal represents a premium of 30.55% from the stockโ€™s last close.
โ˜€๏ธTPG will be taking Altus Power private through this deal, which is expected to close in Q2 2025.
tweet
Offshore
Photo
โ InsideArbitrage
๐Ÿ“ข $BDX BD Announces Strategic Separation

BD (Becton, Dickinson and Company) plans to separate its Biosciences and Diagnostic Solutions business from the rest of BD.

๐Ÿ” The separation decision follows a comprehensive business portfolio evaluation launched in early 2024.

๐Ÿฅ New BD - Pure-Play MedTech
After the separation, New BD will focus on high-growth markets with four key segments:
โ€ข Medical Essentials
โ€ข Connected Care
โ€ข BioPharma Systems
โ€ข Interventional

๐Ÿ“Š New BD Financial Outlook:
โ€ข Expected FY24 revenue: ~$17.8 billion.
โ€ข Addressable market: Over $70 billion, growing at ~5%.
โ€ข Over 90% recurring revenue, supporting robust cash flow & margin enhancement.

1/3
tweet
โ Hidden Value Gems
If you use ChatGPT to summarise earning calls of your portfolio companies (instead of listening/reading transcripts), you probably hold too many stocks. Do you agree?
- Yes
- No
- I am ChatGPT/DeepSeek etc
- I dont understand the Q
tweet
Offshore
Photo
โ Dimitry Nakhla | Babylon Capitalยฎ
Amazon Will Report Q4 Earnings Today ๐Ÿ—“๏ธ

๐Ÿ“ˆRevenue Estimate: $187.23B | +10% YoY

๐Ÿ“ˆEPS Estimate: $1.48 | +48% YoY

What to watch for ๐Ÿ‘‡๐Ÿฝ

1๏ธโƒฃIn $AMZN last report, AWS grew 19.1% YoY, reaching a $110B annualized run rate

2๏ธโƒฃAds revenue grew 18.8% YoY, reaching $14.33B in Q3 2024 https://t.co/3hZUle6wV8
tweet
Offshore
Photo
โ Stock Analysis Compilation
Deep Sail Capital on Shelly Group $SLYG BU

Thesis: Shelly Group is strengthening its position in the smart home market through innovative software integration, strategic expansion, and a commitment to sustainability, all while achieving significant revenue growth and a favorable valuation.

(Extract from their Q4 letter)
tweet
โ Quiver Quantitative
RT @InsiderRadar: ๐ŸšจBREAKING: New Insider Purchase

A director of $JBLU has just reported purchasing $614K of the company's stock, increasing his ownership stake by 608%.

This is the first insider purchase we have seen at the company in over 3 years.
tweet
Offshore
Photo
โ Investing visuals
Would you rather buy $GOOGL or $MSFT right now?๐Ÿค” https://t.co/PjSLhWMgiR
tweet
โ InsideArbitrage
The acquisition of Revance Therapeutics $RVNC by Crown Laboratories was completed on February 6, 2025.

It took 178 days for the deal to be completed.

Crown Laboratories and Revance Therapeutics announced that the tender offer to purchase all of Revance's outstanding shares at $3.65 per share expired on February 4, 2025.

The companies expect to consummate the acquisition on February 6, 2025.
- InsideArbitrage
tweet